Biography

Dr. Kollmann received his M.D. Ph.D. (Microbiology & Immunology) at the Albert Einstein College of Medicine, Bronx NY, and graduated with distinction as an AOA National Honor Medical Society scholar. He received his training in Pediatrics at Children’s Hospital and Regional Medical Center in Seattle at the University of Washington where he also completed a Fellowship in Pediatric Infectious Disease. During his clinical training at the U. of Washington with the support of the Pfizer Postdoctoral Fellowship in Infectious Diseases. His clinical interests and expertise span all of pediatric infectious diseases, but with special emphasis on the newborn and immune compromised individual. Following his dream to optimize neonatal vaccination, Dr. Kollmann has begun to unravel the principles guiding the neonatal innate and adaptive immune system, employing state-of-the art technologies in molecular and cellular immunology. One of the major differences between the adult and neonatal immune system appears to affect adjuvant activity on antigen presenting dendritic cells, and Dr. Kollmann has embarked on a detailed developmental analysis focusing on signaling pathways in these cells in the hope of identifying improved approaches for early life immunization. Dr. Kollmann also has developed a novel neonatal vaccine platform that protects newborn mice from infections. His recent work has been recognized through award of the Burroughs Wellcome Fund Career Award in the Biomedical Sciences as well as a career award from the Canadian Child Health Clinician Scientist Program.